Literature DB >> 10320114

Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction.

M S Cappell1, F M Iacovone.   

Abstract

PURPOSE: To analyze the risks versus benefits of esophagogastroduodenoscopy performed soon after myocardial infarction. PATIENTS AND METHODS: We studied 200 patients who underwent endoscopy within 30 days after myocardial infarction with 200 controls matched for age, sex, and endoscopic indication who underwent endoscopy without a history of myocardial infarction within the prior 6 months. Odds ratios (OR) and 95% confidence intervals (CI) are reported.
RESULTS: The indications for endoscopy included hematemesis in 88, melena in 43, fecal occult blood and anemia in 33, red blood per rectum in 13, abdominal pain in 13, and other indications in 10. Endoscopy was performed a mean (+/- SD) of 9.1 +/- 8.9 days after myocardial infarction, was diagnostic in 85% of all the patients, and was more frequently diagnostic when performed for hematemesis or melena than when performed for other indications (92% vs 71%, P <0.0003). Common diagnoses included duodenal ulcer, gastric ulcer, gastritis, and esophagitis. Fifteen post-myocardial infarction patients (7.5%) suffered endoscopic complications, including fatal ventricular tachycardia (n = 1), near respiratory arrest (n = 1), mild hypotension (n = 11), and moderate hypoxemia (n = 2), compared with three patients (1.5%) in the control group (OR = 5.3, CI = 1.5 to 19). Patients who had endoscopic complications after myocardial infarction had a significantly higher APACHE II score than those who did not (mean score of 17.3 +/- 5.8 vs 11.7 +/- 5.7, P <0.001). Endoscopic complications occurred in 21% (12 of 58) of post-myocardial infarction patients who were very ill (APACHE II score > or = 16) but in only 2% (3 of 142) of those whose condition was relatively stable (APACHE II score < or = 15, OR = 12; CI = 3.3 to 45). Hypotension before endoscopy and a high APACHE II score were independent risk factors for complications in post-myocardial infarction patients.
CONCLUSIONS: Relatively stable patients with upper gastrointestinal bleeding and recent myocardial infarction can and should undergo esophagogastroduodenoscopy. Most endoscopic complications in these patients are cardiopulmonary, and they generally occur in very ill patients.

Entities:  

Mesh:

Year:  1999        PMID: 10320114     DOI: 10.1016/s0002-9343(98)00363-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Safety of esophagogastroduodenoscopy within 30 days of myocardial infarction: a retrospective cohort study from a Canadian tertiary centre.

Authors:  Fahad Al-Ebrahim; Khurram J Khan; Waleed Alhazzani; Ahmed Alnemer; Abdullah Alzahrani; John Marshall; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel.

Authors:  Fook Hong Ng; Pierre Chan; Chi Pong Kwanching; Ching Kong Loo; Ting Kin Cheung; Siu Yin Wong; Carolyn Kng; Ka Man Ng; Sik To Lai; Benjamin Chun Yu Wong
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

4.  Stress-related Mucosal Disease.

Authors:  Mitchell J. Spirt
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 5.  Therapeutic endoscopy for acute upper gastrointestinal bleeding.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

6.  Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes.

Authors:  Mouaz Al-Mallah; Rasha N Bazari; Michelle Jankowski; Michael P Hudson
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

7.  Safety and efficacy of nasogastric intubation for gastrointestinal bleeding after myocardial infarction: an analysis of 125 patients at two tertiary cardiac referral hospitals.

Authors:  Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

8.  A pilot study of single-use endoscopy in screening acute gastrointestinal bleeding.

Authors:  Jae Hee Cho; Hee Man Kim; Sangheun Lee; Yu Jin Kim; Ki Jun Han; Hyeon Geun Cho; Si Young Song
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 9.  Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis.

Authors:  Patrick Yachimski; Chin Hur
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

10.  Safety of push enteroscopy after recent myocardial infarction.

Authors:  Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.